Purple Biotech (PPBT) Cash & Equivalents Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | -24.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.78% |
| Dec 31, 2025 | 17.78% |
| Sep 30, 2025 | 36.10% |
| Jun 30, 2025 | -27.41% |
| Mar 31, 2025 | -25.88% |
| Dec 31, 2024 | -48.92% |
| Sep 30, 2024 | -64.00% |
| Jun 30, 2024 | -62.07% |
| Mar 31, 2024 | -54.37% |
| Dec 31, 2023 | -3.60% |
| Sep 30, 2023 | 36.39% |
| Jun 30, 2023 | 57.96% |
| Mar 31, 2023 | -7.03% |
| Dec 31, 2022 | 38.02% |
| Sep 30, 2022 | -1.54% |
| Jun 30, 2022 | 3.32% |
| Mar 31, 2022 | 130.87% |
| Dec 31, 2021 | -3.17% |
| Jun 30, 2021 | -83.27% |
| Dec 31, 2020 | 156.49% |
| Jun 30, 2020 | 2,184.91% |
| Dec 31, 2019 | -15.07% |
| Jun 30, 2019 | -48.59% |
| Dec 31, 2018 | 30.81% |
| Jun 30, 2018 | -20.64% |
| Dec 31, 2017 | -41.60% |
| Jun 30, 2017 | -35.99% |
| Dec 31, 2016 | -35.99% |
| Dec 31, 2015 | 704.11% |
| Sep 30, 2015 | -59.53% |